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Efficient recellularisation of 
decellularised whole-liver grafts 
using biliary tree and foetal 
hepatocytes
Satoshi Ogiso, Kentaro Yasuchika, Ken Fukumitsu, Takamichi Ishii, Hidenobu Kojima, 
Yuya Miyauchi, Ryoya Yamaoka, Junji Komori, Hokahiro Katayama, Takayuki Kawai, 
Elena Yukie Yoshitoshi, Sadahiko Kita, Katsutaro Yasuda & Shinji Uemoto
A whole-organ regeneration approach, using a decellularised xenogeneic liver as a scaffold for the 
construction of a transplantable liver was recently reported. Deriving suitable scaffolds was the first 
step towards clinical application; however, effective recellularisation remains to be achieved. This 
report presents a strategy for the improvement of the recellularisation process, using novel cell-seeding 
technique and cell source. We evaluated recellularised liver grafts repopulated through the portal vein 
or the biliary duct with mice adult hepatocytes or E14.5 foetal hepatocytes. More than 80% of the 
cells seeded through the biliary tree entered the parenchyma beyond the ductule-lining matrix barrier 
and distributed throughout the liver lobule. In contrast, about 20% of the cells seeded through the 
portal tree entered the parenchyma. The gene expression levels of foetal hepatocyte albumin, glucose 
6-phosphatase, transferrin, cytokeratin 19, and gamma-glutamyl transpeptidase were increased in 
three-dimensional cultures in the native liver-derived scaffolds, and the activation of liver detoxification 
enzymes and formation of biliary duct-like structures were supported. The metabolic functions of liver 
grafts recellularised with different cell types were similar. These results suggest that biliary tree cell-
seeding approach is promising, and that liver progenitor cells represent a good cell source candidate.
Liver transplantation is the ultimate treatment for end-stage liver failure; however, donor organ shortage presents a 
serious problem. The development of alternative options for liver replacement is necessary, and cell-based therapy 
and tissue regeneration have been studied, but satisfactory outcomes have not yet been achieved. Therefore, the 
construction of a fully functional transplantable liver is needed. Three factors are considered essential for organ 
engineering: tissue-specific cells, scaffolding biomaterials, and the appropriate environment for the promotion of 
tissue formation1. The construction of a three-dimensional (3D) organ scaffold with a complex structure is tech-
nically challenging, and the lack of adequate scaffolds has impeded whole-organ engineering. Recently, a decellu-
larisation technique was successfully adapted for the generation of 3D solid organ scaffolds, such as heart2, lung3, 
liver4,5, and kidney6. During decellularisation, cells are removed from the extracellular matrix (ECM) of the native 
organ, and a 3D organ scaffold is produced, while retaining tissue-specific 3D ultrastructure and composition, 
intact vascular networks for nutrient and gas exchange, and functional and structural molecules4. These features 
have made decellularisation a near-ideal choice for the fabrication of suitable scaffolds for whole-organ regener-
ation. Several studies have reported whole-liver regeneration using decellularised liver scaffolds, and this process 
consists of multiple steps—the decellularisation of a donor liver, repopulation of the decellularised liver scaffold 
(recellularisation), re-establishment of a functional liver graft through an in vitro culture, and the implantation of 
the engineered liver in vivo4,5,7,8. Obtaining suitable scaffolds represents the first step in the process; however, in 
order for this process to be applicable in a clinical setting, effective recellularisation needs to be achieved prior to 
the implantation, together with the reestablishment of the parenchyma, vasculature, and supporting components. 
Establishing efficient seeding methods and finding clinically relevant, renewable cell sources are the main issues 
that require solutions to improve previous recellularisation strategies that mainly utilise the portal vein (PV) as a 
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seeding route4,5,7 and primary hepatocytes as a cell source4,7. Here, we have investigated a new seeding approach, 
using the biliary tree as a parenchyma repopulation pathway, and foetal hepatocytes as a cell source.
Results
Characterisation of decellularised liver scaffold. Translucent acellular scaffold, which retained the 
gross anatomical features of the liver, was generated after 24 h of decellularisation procedure. Histological eval-
uation of the decellularised liver scaffolds showed the absence of nuclei or cytoplasmic components in the scaf-
folds (Fig. 1A). Residual DNA content in the decellularised liver scaffolds was shown to be 0.132 ± 0.017 μ g/g 
liver, demonstrating that more than 99% of the total DNA content was removed from the native liver tissue 
(43.4 ± 6.42 μ g/g liver, p < 0.01) (Fig. 1B).
Quantification of ECM components indicated that a 100% of the fibrillary collagen of the native liver was 
retained after decellularisation (0.33 ± 0.04 mg/g of native liver, compared with 0.33 ± 0.06 mg/g of decellular-
ised liver) (Fig. 1C). Additionally, 46% of the sulfated glycosaminoglycans were retained after decellularisation 
(2.4 ± 0.2 mg/g, in the native liver, compared with 1.1 ± 0.1 mg/g of the decellularised liver) (Fig. 1D). Liver 
vasculature dyeing showed that all three vascular systems, portal, arterial, and biliary trees, were intact after 
the decellularisation (Fig. 1E), allowing recellularisation and perfusion culture. Furthermore, the blue dye was 
observed to flow from the portal main vessels to the smaller capillaries (Fig. 1E, leftmost panel), colouring the 
liver parenchyma next (Fig. 1E, second panel from the left), and it was finally drained into the central venous 
system, indicating that the decellularised liver scaffold retained the polarity of perfusion from the Glissonian area 
to the central area.
Seeding route for the efficient repopulation of scaffold: portal vein versus biliary duct. The 
engraftment efficiency of mouse primary hepatocytes was always more than 98% after either PV or biliary duct 
(BD)-seeding. After PV-seeding, the portal tree was clogged with injected cells, as observed by gross inspection, 
Figure 1. Characterisation of decellularised liver scaffolds. (A) H&E and Masson’s trichrome staining 
showed no remaining nuclei or cytoplasm in the scaffolds. (B) Quantification of double-stranded DNA 
revealed that the decellularisation procedure eliminated more than 99% DNA content in the native livers. (C,D) 
Quantification of ECM components indicated that a 100% of the fibrillary collagen (C) and 46% of the sulfated 
glycosaminoglycans (sGAG) (D) were retained after decellularisation. All error bars represent standard error of 
mean (SEM; n = 3) (※p < 0.05). (E) Intrahepatic vasculature, demonstrating the integrity of the portal tree (early 
phase; (E, leftmost panel), late phase; (E, second panel from the left)), arterial tree (E, second panel from the 
right), and biliary tree (E, rightmost panel).
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and using light and fluorescence microscope evaluation (Fig. 2a). Histological evaluation revealed that the major-
ity of cells remained within the portal branches and only small populations were distributed throughout the 
parenchyma at 60 h of perfusion culture (Fig. 2b). In contrast to this, cell clusters were observed outside of the 
biliary tree, 0033 h after BD-seeding (Fig. 2c). Haematoxylin-eosin (H&E) staining showed that a significantly 
higher proportion of cells was distributed in the parenchyma after BD-seeding (Fig. 2d) compared with the 
PV-seeding (81.3% versus 20.1%, respectively, p < 0.01) (Fig. 2e). Furthermore, engrafted cells were distributed 
around central veins (Fig. 2d), which indicated that cells entered the peri-portal area of the parenchyma beyond 
the barrier of ductule lining ECM, and they subsequently reached the peri-central area across the lobular honey-
combed ECM (Fig. 2f).
Cell source for advanced hepatic function and architecture: adult versus foetal hepatocytes. 
Gene expression analysis was performed to investigate the effect of native liver-derived ECM on foetal cells in 
the scaffolds, which were seeded through BD and cultivated for 3 days, and the results were compared with gene 
expression levels in the cells in 2D cultures. The levels of hepatocyte-specific proteins, albumin, alpha-1 antit-
rypsin (A1AT), glucose 6-phosphatase (G6P), and transferrin were increased in the scaffold cells (Fig. 3a–d), in 
comparison with the levels in the cells in 2D cultures, although the difference in A1AT level was not significant. 
Additionally, the levels of cytokeratin 19 and gamma-glutamyl transpeptidase (GGT) were higher in the scaffold 
cells compared with those in the cells in 2D cultures (Fig. 3e,f), which indicates that decellularised liver scaffolds 
enhance the maturation of foetal hepatocytes into both hepatocyte and cholangiocyte lineages.
Immunohistochemical staining of recellularised liver sections was performed at day 2, to evaluate the mor-
phological, functional, and differentiation characteristics of engrafted cells, which were seeded through BD. 
TUNEL-positive cells were quantified, which showed that less than 5% of the cells were apoptotic in either adult 
hepatocyte-recellularised liver grafts (AL) or foetal hepatocyte-recellularised liver grafts (FL) (Fig. 4A). The archi-
tecture and the expression levels of albumin, a liver-specific protein expressed at the early differentiation stage, 
and CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) and UGT1A1 (UDP glucuronosyltrans-
ferase 1 family, polypeptide A1), the liver-specific enzymes acquired at late differentiation stage, were similar in 
both native adult livers and ALs (Fig. 4B), indicating that hepatocyte viability and function were maintained in 
ALs. Albumin, CYP3A4, and UGT1A1 were expressed in FLs, while only albumin, but not CYP3A4 or UGT1A1, 
was expressed in the native E14.5 livers (Fig. 4B). Cytokeratin 19-, a cholangiocyte marker, positive cells were 
Figure 2. Cell distribution analyses. (a) Gross and fluorescence microscopic observations 3 h after portal vein 
(PV)-seeding. (b) H&E staining of recellularised liver sections after PV-seeding, revealing that the majority 
of cells remained within portal branches at 60 h. (c) Gross and fluorescence microscopic observations 3 h after 
biliary duct (BD)-seeding. (d) H&E staining of recellularised liver sections after BD-seeding, revealing massive 
cell distribution around central veins. (e) The percentage of cells distributed in the parenchyma after BD-
seeding or PV-seeding. (f) Schematic illustration of the migration of seeded cells in the liver lobule (HA, hepatic 
artery). Scale bars: 250 mm (a,c) and 100 μ m (b,d). All error bars represent standard error of mean (SEM; n = 3) 
(※ p < 0.05).
www.nature.com/scientificreports/
4Scientific RepoRts | 6:35887 | DOI: 10.1038/srep35887
observed in FLs, together with the formation of many tubular structures, while its expression was not found in 
native E14.5 livers. Additionally, alpha-fetoprotein-, an immature hepatocyte marker, positive cells were observed 
in whole sections of native E14.5 livers, but only in a portion of FLs (Fig. 4B), suggesting that foetal hepatocytes 
maturated into hepatocytes, and obtained higher liver-enzyme functions, or into cholangiocytes, constructing 
BDs during cultivation in liver scaffolds.
The cell proliferation rates of adult and foetal hepatocytes were compared using Ki67 staining at day 2, which 
demonstrated that a higher proportion of engrafted cells was Ki67-positive in FLs than in ALs (2.03% versus 
0.20%, respectively, p < 0.01) (Fig. 5A,B). The viability of the engrafted hepatocytes was assessed by the analysis of 
AL and FL DNA content at week 1. DNA content in ALs was determined to be 44.9 ± 12.0% of the same number 
of freshly isolated adult hepatocytes, while in FLs it was 92.7 ± 9.4% of the same number of freshly isolated foetal 
hepatocytes (p = 0.03) (Fig. 5C), indicating a higher survival capacity of foetal hepatocytes in the scaffolds.
To assess the metabolic activity of recellularised liver grafts, albumin production and urea synthesis were 
quantified. The cumulative albumin production in FLs during 7-day culture was 10.19 ± 0.85 μ g/106 cells, and 
this was higher than that in ALs (5.37 ± 0.99 μ g/106 cells, p < 0.01) and that in adult hepatocytes cultivated in 
the traditional 2D cultures (4.24 ± 0.94 μ g/106 cells, p < 0.001) (Fig. 5D). The cumulative urea synthesis was 
1.58 ± 0.14 mg/106 cells in ALs, 1.28 ± 0.21 mg/106 cells in FLs, and 1.13 ± 0.02 mg/106 cells in the traditional 
culture of adult hepatocytes. No significant differences were observed here (Fig. 5E).
Discussion
Here, we present a strategy to improve the recellularisation process and further develop the whole-organ regener-
ation approach initiated with the derivation of decellularised scaffolds4,5,7–9, in order to achieve the reconstruction 
of clinically relevant liver grafts. Recellularisation should lead to the complete reorganisation of complex liver lob-
ular architecture, consisting of the parenchyma, vasculature, and supporting components, and the refinement of 
the seeding method and the determination or generation of a clinically available cell source are necessary. To the 
best of our knowledge, this is the first study presenting an efficient seeding method using the biliary tree, which 
allows whole-lobular cell distribution, while allowing the portal tree to be used for subsequent reintroduction of 
endothelial and other non-parenchymal cells. Additionally, we demonstrate that foetal hepatocytes, representing 
an experimental surrogate for induced pluripotent stem cell (iPSC)-derived liver progenitor cells, integrate biliary 
structures into liver lobules and provide hepatocytic functions not inferior to the functions of mature hepato-
cytes, when used as a cell source for whole-liver regeneration.
Figure 3. Gene expression analysis. Normalised gene expression levels of albumin (a), A1AT (b), G6P  
(c), transferrin (d), cytokeratin 19 (e), and GGT (f). All error bars represent standard error of mean  
(SEM; n = 3) (※p < 0.05).
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Based on the previously established decellularisation technique4,5,7, we succeeded in achieving complete decel-
lularisation, while preserving native ECM components and intact vascular networks. Previously established sys-
tems for perfusion culture4,5,7 were replicated in this study as well, and their adequacy was demonstrated by the 
fact that the viability of adult hepatocytes was over 95% at day 2, and they retained hepatocyte enzyme expres-
sions of CYP3A4 and UGT1A1. Additionally, previous recellularisation methods, mainly using PV as a seeding 
route and primary hepatocytes as a cell source, were modified in order to evaluate BD seeding method, and the 
use of a different cell source, foetal hepatocytes, for the improvement of morphology and functionality of recon-
structed liver grafts.
PV has been widely accepted as a route for the repopulation of the liver parenchyma4,5,7,8, and multi-step 
infusion technique has been recommended for PV-seeding method4,7 in order to prevent portal clogging, which 
was observed after single-step infusions4. However, several days of perfusion are necessary even when this tech-
nique is used, in order to allow the seeded cells to leave the vessels and distribute throughout the parenchyma4, 
Figure 4. Morphological characterisation of foetal hepatocyte-recellularised liver grafts. (A) Quantification 
of apoptosis by TUNEL staining in DNase I-treated liver sections (positive control), adult hepatocytes, and 
foetal hepatocytes, showing that less than 5% of the cells were apoptotic at day 2. (B) Histological comparison 
of native and recellularised liver grafts. Left to right: native adult liver, adult hepatocyte-recellularised liver graft 
(AL), foetal hepatocyte-recellularised liver graft (FL), native foetal liver. Top to bottom: H&E, albumin (ALB, 
green) and cytokeratin 19 (CK19, red), alfa-feto protein (AFP, green) and CYP3A4 (red), and UGT1A1 (green) 
and CK19 (red). All sections were counterstained with DAPI (blue). Scale bars: 100 μ m (A) and 50 μ m (B).
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which raises a concern about the risk of pressure injury to the intravascular hepatocytes. The evaluation of other 
seeding routes was necessary, in order to facilitate an efficient cell distribution and integration with further PV 
reintroduction of multiple types of residing cells. We evaluated cell seeding through BD for the first time, and 
showed that the engraftment efficacy is more than 95% and parenchymal distribution efficacy higher than 80%, 
following the BD-seeding. This approach does not require excessive or additional pressure, as required during 
PV-seeding, for the deposition of cells in the parenchyma, and the lack of pressure injury leads to the high cell 
viability. The much higher efficiency of parenchymal distribution during BD-seeding, compared with PV-seeding 
can be explained by the lobular microanatomy, where the liver sinusoid and parenchyma are separated by the 
space of Disse, whereas biliary canaliculus is composed of hepatocytes, and directly in contact with the paren-
chyma. Additionally, we found cells distributed around central veins and throughout the lobule after BD-seeding, 
which suggests that the liver lobules can be entirely repopulated by BD-seeding, regardless of zonation, although 
a previous study reported areal limitation of the seeding through vena cava, in which the cells were deposited in 
the peri-central area, and PV-seeding, where the cells were deposited in the peri-portal area5. Using our approach, 
the parenchyma can be recellularised through BD, while the vasculatures can be re-endothelialised through the 
PV (and the seeding through vena cava and hepatic artery), in contrast to PV-seeding, where the seeded hepato-
cytes remain within the PV and disrupt the subsequent re-endothelialisation. This integration of seeding routes 
confirms the concepts presented in previous reports, suggesting that the use of multiple routes may facilitate the 
spatial arrangement of cells10. Based on the obtained results, the evaluation of the cell sources was performed 
using BD-seeding approach.
The lack of an abundant source of human cells represents a major limitation in the regenerative medicine 
for liver support, and determining the appropriate cell source is a main challenge for the clinical application of 
assembled liver grafts. Foetal tissues are considered a potential source of human cells for liver engineering5,11, 
but it is currently unclear whether foetal cells can be sufficiently expanded for clinical applications12 or whether 
they can properly differentiate and function. Here, prior to comparing adult and foetal hepatocytes, we assessed 
whether decellularised liver scaffolds enhance the maturation of foetal hepatocytes, and demonstrated the exist-
ence of organ-specific cell–ECM communication, which promotes the maturation of engrafted foetal hepato-
cytes into both hepatocyte and cholangiocyte lineages, without the addition of any pro-differentiation signals. 
This agrees with the previous studies that were performed using mouse mesenchymal stem cells (MSC)13 and 
human hepatic stem cells14 in liver scaffolds and mouse embryonal stem cells (ESC) in kidney scaffolds15,16. 
Immunohistochemical evaluation showed that foetal hepatocytes were mainly immature (alfa-feto protein 
[AFP]+ albumin+ CYP3A4- UGT1A1- cytokeratin 19-) in the native foetal liver, but they maturated into the two 
Figure 5. Functional comparison of adult and foetal hepatocyte-recellularised liver grafts.  
(A,B) Quantification of cell proliferation at day 2 using anti-Ki67 staining in adult (ALs) and foetal (FLs) 
hepatocyte-recellularised liver grafts. (C) Quantification of DNA levels at day 7 in ALs and FLs as a surrogate 
for the viability of engrafted cells. (D,E) Metabolic activity assessment of ALs and FLs, demonstrating the higher 
cumulative albumin production (D) and non-inferior cumulative urea synthesis (G) of FLs compared with ALs. 
Scale bars: 20 μ m. All error bars represent standard error of mean (SEM; n = 3) (※p < 0.05).
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different lineages (AFP- albumin+ CYP3A4+ cytokeratin 19- and AFP- albumin- CYP3A4- cytokeratin 19+), and 
formed BD-like structures in FLs. These results confirm that multi- or bi-potential precursor liver cells can be 
used for the reconstruction of complex liver lobular architecture, based on the matrix differentiation signals. The 
repopulation of the biliary tree with biliary epithelial cells independently from liver parenchymal cell may present 
an alternative approach, but further investigations are required to develop a technique for the recellularisation of 
biliary tree and achieve functional cooperation between engrafted hepatocytes and cholangiocytes.
Functional assessment revealed that the cells in FLs have the ability to synthesise a larger amount of albumin 
and a similar amount of urea, compared with the cells in ALs. Good functional outcomes of FLs, comparable to 
those of ALs, may be the result of foetal hepatocyte maturation and their subsequent acquiring of advanced hepat-
ocytic functions in the scaffolds. Additionally, the higher proliferation activity and increased viability of the foetal 
hepatocytes compared with the adult hepatocytes, demonstrated by TUNEL-staining and DNA content quanti-
fication, may present the reason for good functional outcomes of FLs. The reproduction of the highly-complex 
native-liver environment, in which even the mature hepatocytes have unlimited proliferative ability, is currently 
unattainable in recellularised liver grafts. Therefore, the use of cell types with high proliferative and survival 
potential ex vivo (i.e., immature hepatocytes) is preferred.
This study, demonstrating the potential of foetal hepatocytes, does not necessarily suggest the widespread 
use of foetal cells, which can raise serious ethical concerns, but it highlights the potential use of iPSC-based 
whole-organ assembly research17. Based on our results, it is possible that iPSC-derived precursor hepatocytes 
would have similar properties as the foetal hepatocytes, allowing the reconstruction of liver grafts with paren-
chymal and biliary components and functions non-inferior to that of the mature hepatocytes, through enhanced 
differentiation. The potential availability of iPSC-derived liver progenitor cells is important, considering the chal-
lenges related to the differentiation of iPSCs to mature hepatocytes with functional and regenerative character-
istics identical to those of the cells residing in the human liver18,19. iPSCs also offer the advantages of indefinite 
propagation in undifferentiated status, supplying their vast quantities, and the potential of differentiation into 
any cell type required for whole-liver assembly. Additionally, the use of autologous recipient-derived iPSCs allows 
the assembly of an entirely non-antigenic liver graft, which eliminates the risk of immunological rejection or 
the need for life-long immunosuppressive therapy. Further investigations of the suitable differentiation stage of 
iPSC-derived cells that can be seeded in the scaffolds and effective medium that can induce differentiation are 
necessary, ultimately using clinically relevant quantities of cells in a human sized-liver scaffold.
In addition to the potential clinical use of engineered livers as grafts in liver transplantation therapy, they can 
be used as 3D culture systems, for the induction of the proliferation and differentiation of various cell types, and 
ex vivo preclinical models for drug metabolism, cell-ECM interactions, and liver development studies, closely 
imitating complex in vivo environment. The deeper understanding of stem cell-ECM niche interactions/stem cell 
fate decision and liver regeneration may be achieved through the development of recellularised liver grafts with 
iPSC-derived cell.
In conclusion, the seeding of cells through the biliary tree is a promising approach for efficient repopulation 
of the parenchyma of liver scaffold. Additionally, foetal hepatocytes represent a good candidate for the cell source 
for whole-liver assembly, supporting the use of iPSC-derived cells in the future studies.
Methods
Animals. Male C57BL/6 mice and C57BL/6 green fluorescent protein (GFP) gene-carrying mice (SLC, 
Hamamatsu, Japan) were used for hepatocyte isolation, and these cells were used to evaluate cell seeding tech-
niques, hepatocyte function, and for histological studies. Male Lewis rats (250–300 g; SLC) were used for liver 
harvesting and the preparation of the 3D liver scaffold. All experimental protocols were approved by the Animal 
Experimentation Committee of Kyoto University and all animal experimental procedures were performed 
according to the Animal Protection Guidelines of Kyoto University.
Donor liver harvest. Rats (8 to 12 weeks old) were anesthetised with isoflurane, and they underwent lap-
arotomy. The gastroduodenal and splenic veins were ligated, and the liver was mobilised. Heparin (0.5 U/g of 
body weight) was administered intravenously. The diaphragm was cut, in order to clamp the aorta in the thoracic 
cavity and to transect the inferior vena cava. The abdominal aorta was cannulated with a 24-gauge cannula, and 
30–40 mL of phosphate-buffered saline (PBS) was injected. The liver was removed, followed by the cannulation of 
PV with an 18-gauge cannula, and BD with a 24-gauge cannula. The livers were stored in a cell culture dish with 
PBS solution and frozen until decellularisation.
Preparation of decellularised whole-liver scaffold. The harvested livers of Lewis rats were decellular-
ised as previously described4,7. Briefly, they were frozen at − 80 °C and thawed at room temperature, which was 
followed by cell-ECM detachment using the perfusion of 0.02% trypsin/0.05% EGTA solution through their PVs 
for 1 h at 37 °C. Subsequently, 1% Triton X-100/0.05% EGTA solution was perfused for 18–24  h at 1 mL/min for 
detergent decomposition and solubilisation (Fig. 6A). The samples were washed with PBS for 1 h, and the decel-
lularised liver scaffold was perfused with 0.1% peracetic acid for 2 h, in order to sterilize it.
Isolation of adult and foetal mouse hepatocytes. Primary adult hepatocytes were obtained from 8- to 
12-week-old male C57BL/6 mice, using a modified two-step collagenase perfusion technique, as we described 
previously20. Briefly, mice were anesthetised with isoflurane, laparotomy was performed, and their PVs were can-
nulated with 25-gauge needles. The livers were then pre-perfused with HBSS-EGTA solution, followed by the per-
fusion with a collagenase solution containing 0.3% dispase II (Sanko Junyaku, Tokyo, Japan) and 0.3% collagenase 
type II (Gibco, Palo Alto, CA, USA). Afterward, the livers were excised, minced with scissors, and incubated at 
37 °C for an additional 20 min in the collagenase solution. After filtering through the 50 N polypropylene mesh, 
www.nature.com/scientificreports/
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the suspension was centrifuged three times at 50 × g for 4 min. The pellets were collected, and hepatocyte viability 
was assessed using trypan blue, and determined to be routinely > 90%.
Primary foetal hepatocytes were isolated from E14.5 mice livers and were enriched through the for-
mation of cell aggregates, as described previously21. Briefly, E14.5 foetal liver tissues were digested by 0.5% 
collagenase-containing medium and foetal hepatocytes were subjected to the floating culture for about 24 h, in 
order to form cell aggregates on Petri dishes. They were selected by gravitational sedimentation and the viability 
was assessed, and confirmed to be > 90%.
The cells were suspended at a density of 1.2 × 106 cells/mL for recellularisation, and cultured in collagen-coated 
dishes (Iwaki, Chiba, Japan) as a control.
Hepatocyte seeding into the parenchyma of scaffolds. A decellularised liver scaffold was placed in 
a 60-mm culture dish, and perfused using RPMI 1640 medium through the PV prior to recellularisation. RPMI 
1640 (Sigma-Aldrich, St. Louis, MO, USA) was supplemented with 10% foetal calf serum (FCS; ICN, Aurora, OH, 
USA), 0.0036 μ g/mL insulin (MP Biomedicals, Santa Ana, CA, USA), 10 ng/mL epidermal growth factor (EGF; 
R&D Systems, Minneapolis, MN, USA), 100 U/mL penicillin G and 100 μ g/mL streptomycin (Meiji Seika, Tokyo, 
Japan), and 20 μ g/mL gentamycin. A total of 6 × 106 cells was suspended in 5 mL of the culture medium and 
introduced into the scaffold through either PV or BD, retained after decellularisation (Fig. 6B). At each step, 1 mL 
of the cell suspension was injected into the scaffold for 1 min, using a peristaltic pump or manually, and the total 
of five steps was performed in 5-min intervals (Fig. 6C). After 3 h of static culture in an incubator, the perfusate 
was collected to count the number of cells not retained in the liver scaffolds (Fig. 6C). The engraftment efficiency 
was calculated as the ratio of the number of cells retained in the liver scaffold to the initial number of seeded cells. 
The adult hepatocytes of wild-type C57BL/6 mice and GFP-positive mice were used for recellularisation, and the 
comparisons of the two seeding routes. Adult and foetal hepatocytes of wild-type C57BL/6 mice were seeded 
through the BD in order to evaluate the capacity of liver progenitor cells as a cell source for liver recellularisation.
Perfusion culture of the recellularised liver graft. After 3 h of static culture, we transferred the recel-
lularised liver graft into a customised chamber for perfusion culture. The recellularised liver graft was connected 
to a recirculation circuit by a cannula inserted into the PV (Fig. 6D) and continuously perfused with RPMI 1640, 
using a peristaltic pump (Masterflex) at a subphysiological flow rate of 0.5 mL/min (Fig. 6C), in order to prevent 
the shear stress and minimize the mechanical damage to engrafted cells. The entire perfusion system was placed 
in a standard CO2 (5%) cell incubator at 37 °C. The perfusate was collected every 60 h and replaced with the fresh 
medium. Histological staining of recellularised sections was performed at day 2 (600’h) of in vitro perfusion cul-
ture. DNA content was evaluated at day 7 (180 h).
Histology and immunohistochemistry. Decellularised liver scaffolds and recellularised liver grafts, 
together with fresh adult and E14.5 foetal mouse livers, were fixed with 4% paraformaldehyde, embedded in par-
affin, and cut into 5-μ m thick sections. H&E staining and Masson’s trichrome staining were performed according 
to the standard protocols, to detect any remaining nuclear materials or cellular components in decellularised liver 
scaffolds. The engraftment of seeded hepatocytes was assessed using H&E staining at 60 h of perfusion culture, 
by calculating the proportions of cells distributed in the parenchyma to a total number of cells in three randomly 
selected fields in each recellularised liver graft.
Ki-67 expression in the engrafted cells was analysed immunohistochemically, in order to assess their prolifer-
ative capacities. The deparaffinised sections were incubated in 3% hydrogen peroxide in methanol for 10 min to 
block endogenous peroxidase activity. Sections were incubated at 4 °C for 16 h with monoclonal rat anti-mouse 
Figure 6. Decellularisation and recellularisation of rat livers. (A) Representative images of rat livers during 
decellularisation process. (B) The bile duct of the scaffold was cannulated to inject cells and the culture medium. 
(C) Recellularisation protocol. (D) Recellularised liver grafts (arrows) were connected to the recirculation 
circuit by a cannula inserted into the portal vein and continuously perfused with the culture medium.
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Ki-67 antibody (1:100; eBioscience, San Diego, CA, USA). After the primary antibody had been washed off, 
the samples were incubated for 60 min with horseradish peroxidase-conjugated anti-rat IgG (Envision Plus Kit; 
Dako, Glostrup, Denmark) and for 1 min with 3,3′ -diaminobenzidine (DAB) substrate (Dako). Counterstaining 
was performed using haematoxylin. The proportion of Ki-67 positive cells to total cells was calculated in two 
randomly selected fields in each recellularised liver graft.
TUNEL staining was performed using an In situ Apoptosis Detection Kit (Takara Bio, Shiga, Japan) according 
to the manufacturer’s protocol. The samples were incubated for 1 min with DAB substrate (Dako) and counter-
stained with methyl green.
Immunofluorescence analysis was performed as previously reported22. Antigen retrieval was performed with 
a Target Retrieval Solution (Dako) and nonspecific binding was blocked with 1.4% bovine serum albumin (BSA; 
Sigma-Aldrich) dissolved in 0.1% saponin (Wako Pure Chemical Industries) in PBS. The sections were incu-
bated overnight at 4 °C with the following primary antibodies: goat polyclonal anti-mouse albumin (1:200; Bethyl 
Laboratories, Montgomery, TX, USA), rabbit polyclonal anti-mouse cytokeratin 19 (1:100; Abcam, Cambridge, 
UK), goat polyclonal anti-mouse alpha-fetoprotein (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), 
rabbit polyclonal anti-mouse CYP3A4 (1:500; Abcam), rabbit polyclonal anti-mouse UGT1A1 (1:300; GeneTex 
Inc, Irvine, CA, USA), and goat polyclonal anti-mouse cytokeratin 19 (1:100; Santa Cruz Biotechnology). 
After washing, the stained sections were incubated with Alexa 488-conjugated donkey anti-goat immunoglob-
ulin (Ig)G (1:500; Invitrogen) and Alexa 555-conjugated donkey anti-rabbit IgG (1:500; Invitrogen), or Alexa 
488-conjugated donkey anti-rabbit IgG (1:500; Invitrogen) and Alexa 555-conjugated donkey anti-goat IgG 
(1:500; Invitrogen) for 2 h at room temperature. Each secondary antibody was diluted at 1:500. After washing, the 
stained sections were covered with Vectashield mounting medium with 4,6-diamidino-2-phenylindole (DAPI; 
Vector Laboratories, Burlingame, CA, USA).
All samples were imaged using a fluorescence microscope BZ-9000 (Keyence, Osaka, Japan).
Vascular tree imaging. The integrity of microvasculature and surface capsule was evaluated by the perfu-
sion of blue dye through the PV and a red dye through the hepatic artery or BD, using peristaltic pump.
Determination of collagen, glycosaminoglycan, and DNA content. Collagen content was meas-
ured indirectly through hydroxyproline content measurements, as described previously23, and the glycosamino-
glycan content was determined using Blyscan Assay (Biocolor, Ltd., Newtownabbey, UK), according to the 
manufacturer’s instructions, in order to compare the amount of ECM components in native rat livers and decel-
lularised liver scaffolds. The measured values were normalised to the weight of normal liver. DNA content was 
measured using Qubit dsDNA HS Assay Kit (Invitrogen, Carlsbad, CA, USA), to ensure the complete removal of 
native cells from the liver scaffolds. DNA content measurements were used also to assess the viability of engrafted 
cells in the liver scaffolds, based on the fact that the amount of DNA in each cell remains constant for a given cell 
type24. The DNA levels of livers recellularised with 6 × 106 adult hepatocytes were normalised to the DNA levels 
of 6 × 106 pre-seeding freshly-isolated adult hepatocytes, while the levels of livers recellularised with 6 × 106 foetal 
hepatocytes were normalised to those of 6 × 106 pre-seeding foetal hepatocytes.
Liver function evaluation. Perfusion culture medium samples were collected every 60 h. Albumin content 
was measured using the mouse albumin ELISA quantitation kit (Bethyl Laboratories), while the urea content 
was analysed using the QuantiChrom Urea Assay Kit (BioAssay Systems, Hayward, CA, USA), according to the 
manufacturers’ protocols.
Quantitative reverse transcription PCR. Total RNA was extracted using a PureLink RNA Mini Kit 
(Invitrogen), and 100–200 ng of total RNA was reverse transcribed into cDNA using a ReverTra Ace (TOYOBO, 
Osaka, Japan) according to the manufacturers’ instructions. Primers for the amplification of albumin, A1AT, G6P, 
transferrin, cytokeratin 19, GGT, and actin-beta (ActB) were generated (Supplementary Table S1). Quantitative 
RT-PCR assay was performed using SYBR-green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on 
the ABI 7500 system (Applied Biosystems). Each experiment was performed in triplicate, and the gene expression 
levels were normalised to the levels of ActB.
Statistical analyses. Data are expressed as mean ± standard error of mean (SEM). We performed statistical 
analyses using GraphPad Prism for Windows, version 6.0 (GraphPad Software, La Jolla, CA, USA). Statistical 
significance was defined as p < 0.05. Cell distribution, mRNA expression levels, cell mitosis, and collagen, gly-
cosaminoglycan, and DNA contents were compared using Student’s t-test. The metabolic activity of recellular-
ised liver grafts was compared using repeated-measures analysis of variance (ANOVA), followed by Bonferroni 
post-tests.
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